Gastric cancer

2018 ◽  
pp. 279-294
Author(s):  
Abdullah Jibawi ◽  
Mohamed Baguneid ◽  
Arnab Bhowmick

Gastric cancer presents in the majority of cases at a locally advanced/metastatic stage. Initial investigations should be on the dyspepsia pathway. Multiple biopsies are necessary from any suspicious endoscopic lesions. Accurate staging and MDT assessment is essential for optimum patient selection for surgery. Endoscopic resection can now be recommended for very early lesions with good prognostic features. In gastrectomy, controversy exists across the world as to the extent of lymphadenectomy. This is discussed, as well as neoadjuvant and adjuvant oncological therapy.

2015 ◽  
Vol 21 (11) ◽  
pp. 2520-2529 ◽  
Author(s):  
Chan-Young Ock ◽  
Keun-Wook Lee ◽  
Jin Won Kim ◽  
Jin-Soo Kim ◽  
Tae-Yong Kim ◽  
...  

2022 ◽  
Vol 11 ◽  
Author(s):  
Matthew R. Woeste ◽  
Khaleel D. Wilson ◽  
Edward J. Kruse ◽  
Matthew J. Weiss ◽  
John D. Christein ◽  
...  

BackgroundIrreversible electroporation (IRE) has emerged as a viable consolidative therapy after induction chemotherapy, in which this combination has improved overall survival of locally advanced pancreatic cancer (LAPC). Optimal timing and patient selection for irreversible electroporation remains a clinically unmet need. The aim of this study was to investigate preoperative factors that may assist in predicting progression-free and overall survival following IRE.MethodsA multi-institutional, prospectively maintained database was reviewed for patients with LAPC treated with induction chemotherapy followed by open-technique irreversible electroporation from 7/2015-5/2019. RECIST 1.1 criteria were used to assess tumor response and radiological progression. Overall survival (OS) and progression-free survival (PFS) were recorded. Survival analyses were performed using Kaplan Meier and Cox multivariable regression analyses.Results187 LAPC patients (median age 62 years range, 21 – 91, 65% men, 35% women) were treated with IRE. Median PFS was 21.7 months and median OS from diagnosis was 25.5 months. On multivariable analysis, age ≤ 61 (HR 0.41, 95%CI 0.21-0.78, p<0.008) and no prior radiation (HR 0.49, 95%CI 0.26-0.94, p=0.03) were positive predictors of OS after IRE. Age ≤ 61(HR 0.53, 95%CI, 0.28-.99, p=0.046) and FOLFIRINOX followed by gemcitabine/abraxane induction chemotherapy (HR 0.37,95%CI 0.15-0.89, p=0.027) predicted prolonged PFS after IRE. Abnormal CA19-9 values at the time of surgery negatively impacted both OS (HR 2.46, 95%CI 1.28-4.72, p<0.007) and PFS (HR 2.192, 95%CI 1.143-4.201, p=0.018) following IRE.ConclusionsAge, CA 19-9 response, avoidance of pre-IRE radiation, and FOLFIRINOX plus gemcitabine/abraxane induction chemotherapy are prominent factors to consider when referring or selecting LAPC patients to undergo IRE.


2016 ◽  
Vol 62 (3) ◽  
pp. 25-32 ◽  
Author(s):  
Pavel L. Okorokov ◽  
Olga V. Vasyukova ◽  
Ivan I. Dedov

Morbid obesity in children is associated with various metabolic complications, often persisting into adulthood and leading to reduced quality and duration of life. Conservative treatment of morbid obesity, often ineffective, and therefore, bariatric surgery in adolescents is becoming more common throughout the world. This review presents an analysis of international clinical guidelines for patient selection for bariatric surgery, assessed the efficiency and safety of different types of bariatric operations and identified the main problems of the widespread use of metabolic surgery as a method of treatment of morbid obesity in adolescents.


2017 ◽  
Vol 8 (6) ◽  
pp. 1009-1017 ◽  
Author(s):  
Naruhiko Ikoma ◽  
Jeffrey H. Lee ◽  
Manoop S. Bhutani ◽  
William A. Ross ◽  
Brian Weston ◽  
...  

2015 ◽  
Vol 56 (4) ◽  
pp. 523-529 ◽  
Author(s):  
Y. Kaneko ◽  
W. K. Murray ◽  
E. Link ◽  
R. J. Hicks ◽  
C. Duong

Sign in / Sign up

Export Citation Format

Share Document